搜索临床试验以:Intraductal
总计240个结果
-
Seoul National University HospitalNational Research Foundation of Korea主动,不招人
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的
-
Atossa Therapeutics, Inc.Covance; Illumina, Inc.完全的
-
Andrea DeCensiEuropean Institute of Oncology; Associazione Italiana per la Ricerca sul Cancro主动,不招人
-
Xoft, Inc.Icad, Inc.主动,不招人
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI); Eastern Cooperative Oncology Group主动,不招人
-
The University of Hong KongFood and Health Bureau, Hong Kong Government主动,不招人
-
Rutgers, The State University of New JerseyRutgers Cancer Institute of New Jersey; Elekta Limited; Cianna Medical, Inc.完全的浸润性乳腺癌 | IA期乳腺癌 | IB 期乳腺癌 | IIA期乳腺癌 | 雌激素受体阳性 | 孕激素受体阳性 | 乳腺导管原位癌美国
-
University of Chicago主动,不招人肺转移 | 肝转移 | 男性乳腺癌 | IV 期乳腺癌 | 复发性乳腺癌 | 浸润性小叶乳腺癌 | 中枢神经系统转移 | 脑转移瘤 | 小叶性乳腺癌原位癌 | 浸润性导管癌 | 伴有淋巴细胞浸润的髓样导管癌 | 粘液性导管乳腺癌 | 乳头状导管癌 | 管状导管癌 | 以导管内成分为主的浸润性导管乳腺癌 | 原位成分为主的浸润性小叶乳腺癌美国
-
Ohio State University Comprehensive Cancer Center主动,不招人IA期乳腺癌 | IB 期乳腺癌 | 雌激素受体阳性乳腺癌 | 孕激素受体阳性乳腺癌 | 浸润性导管癌 | 伴有淋巴细胞浸润的髓样导管癌 | 粘液性导管乳腺癌 | 乳头状导管癌 | 管状导管癌 | 以导管内成分为主的浸润性导管乳腺癌美国
-
Trans Tasman Radiation Oncology GroupEuropean Organisation for Research and Treatment of Cancer - EORTC; NCIC Clinical Trials Group; ETOP IBCSG Partners Foundation 和其他合作者主动,不招人
-
Northwestern UniversityNational Cancer Institute (NCI)完全的0 期乳腺癌 | IA期乳腺癌 | IB 期乳腺癌 | IIA期乳腺癌 | IIB期乳腺癌 | 小叶乳腺癌原位癌 | 乳腺导管原位癌 | BRCA1突变携带者 | BRCA2突变携带者美国
-
Zealand University HospitalCopenhagen University Hospital, Denmark完全的
-
Seoul St. Mary's Hospital邀请报名
-
National Cancer Institute (NCI)完全的
-
Mayo ClinicNational Cancer Institute (NCI)主动,不招人雌激素受体阳性 | 乳腺导管原位癌 | 1 级浸润性乳腺癌 | 2 级浸润性乳腺癌 | 3 级浸润性乳腺癌 | 浸润性导管和小叶原位癌 | 粘液性乳腺癌 | 管状乳腺癌美国
-
Theresienkrankenhaus und St. Hedwig-Klinik GmbHUniversity Hospital Heidelberg完全的
-
Sentara Norfolk General HospitalGeorge Mason University; Dorothy G. Hoefer Foundation完全的
-
University of Texas Southwestern Medical Center完全的解剖学 I 期乳腺癌 AJCC v8 | 解剖学 IA 期乳腺癌 AJCC v8 | 解剖学 IB 期乳腺癌 AJCC v8 | 解剖学 II 期乳腺癌 AJCC v8 | 解剖学 IIA 期乳腺癌 AJCC v8 | 解剖学 IIB 期乳腺癌 AJCC v8 | 解剖学 IIIA 期乳腺癌 AJCC v8 | 预后 I 期乳腺癌 AJCC v8 | 预后 II 期乳腺癌 AJCC v8 | BRCA1突变 | BRCA2突变 | 导管原位癌美国
-
Instituto Ecuatoriano de Enfermedades Digestivas主动,不招人
-
National Cancer Institute (NCI)完全的IIIA期乳腺癌 | IIIB期乳腺癌 | 浸润性乳腺癌 | IA期乳腺癌 | IB 期乳腺癌 | IIA期乳腺癌 | IIB期乳腺癌 | IIIC期乳腺癌 | 小叶乳腺癌原位癌 | 乳腺导管原位癌 | 乳腺佩吉特病 | 良性乳腺肿瘤美国
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)终止
-
University of Texas at AustinWashington University School of Medicine; Ohio State University完全的
-
Soonchunhyang University HospitalMinistry of Health & Welfare, Korea主动,不招人
-
Inova Health Care ServicesUnited States Department of Defense; U.S. Army Medical Research and Development Command; University... 和其他合作者完全的
-
Helsinki University Central Hospital完全的
-
Jaroslaw HepelBrown University; Rhode Island Hospital; Women and Infants Hospital of Rhode Island撤销乳腺癌 | 浸润性乳腺癌 | 导管原位癌
-
First Hospital of China Medical UniversityJilin Provincial Tumor Hospital; The First Hospital of Jilin University; Second Hospital of Jilin... 和其他合作者未知
-
Abramson Cancer Center of the University of PennsylvaniaNational Cancer Institute (NCI)完全的